Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 29
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase II Chemotherapy with Spirogermanium for Advanced Gynecologic Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
70 and under
UMCC-8036
2.
Phase II Master Protocol to Evaluate Chemotherapeutic Agents or Combinations for Refractory Malignant Glioma --- SPG
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI
EST-1382
3.
Phase II Chemotherapy with Spirogermanium for Advanced Stage III/IV Adenocarcinoma of the Breast
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI
EST-PB-181
WCCC-CO-8012
4.
Phase II Master Protocol Chemotherapy with New Single Agents in Patients with Stage II/III non-Small Cell Carcinoma of the Lung --- Spirogermanium
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI
ICC-81L3
NCI-T83-0925D, T83-0925
5.
Phase II Chemotherapy with Spirogermanium in Metastatic Lung Cancer of All Histologies
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
15 and over
MDA-DM-8287
NCI-C83-0419
6.
Phase II Chemotherapy with Spirogermanium for Metastatic Malignant Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI
SWOG-8240
7.
Phase II Chemotherapy with Spirogermanium for Renal Cell Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI
SWOG-8218
8.
Phase II Chemotherapy with Spirogermanium for Metastatic Gastric, Colorectal, and Miscellaneous Gastrointestinal Malignant Neoplasms
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
15 and over
MDA-DT-8173
NCI-C83-0555
Last Modified:
6/1/1997
9.
Phase II Master Protocol for Single-Agent Chemotherapy for Previously Treated Stage III/IV Hodgkin's and non-Hodgkin's Lymphoma --- PALA, AMSA, SPG, DCF (Summary Last Modified 06/97).
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
15 to 76
NCI
EST-1480
Last Modified:
6/1/1997
10.
Phase II Master Protocol Chemotherapy for Metastatic or Recurrent Gastric Cancer --- VP-16 vs DHAD (Summary Last Modified 06/97).
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
EST-5282
Select All on One Page
1
2
3
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute